Study on the Efficacy of Sacubitril/Valsartan in Patients with Heart Failure with Preserved Ejection Fraction Undergoing Peritoneal Dialysis.

Sheng, Yuping; Ma, Xiaoying; Liu, Ye; Yang, Xingmeng; Sun, Fuyun

Sheng, Yuping; Ma, Xiaoying; Liu, Ye; Yang, Xingmeng; Sun, Fuyun.

Afiliação

Sheng Y; Department of Nephrology, Cangzhou Central Hospital, Cangzhou, China.
Ma X; Department of Nephrology, Cangzhou Central Hospital, Cangzhou, China.
Liu Y; Department of Nephrology, Cangzhou Central Hospital, Cangzhou, China.
Yang X; Department of Nephrology, Cangzhou Central Hospital, Cangzhou, China.
Sun F; Department of Nephrology, Cangzhou Central Hospital, Cangzhou, China.

Cardiology ; 148(5): 385-394, 2023.

Article em En | MEDLINE | ID: mdl-37253340

Assuntos

Insuficiência Cardíaca; Valsartana; Humanos; Compostos de Bifenilo; Combinação de Medicamentos; Insuficiência Cardíaca/tratamento farmacológico; Volume Sistólico/fisiologia; Valsartana/uso terapêutico; Função Ventricular Esquerda/fisiologia

Palavras-chave

24h ultrafiltration volume; Cardiac function; Efficacy; Heart failure with preserved ejection fraction; N-Terminal pro-brain natriuretic peptide; Peritoneal dialysis; Sacubitril/valsartan; Volumetric loading

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Valsartana / Insuficiência Cardíaca Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google